- Home
- PODD vs EQR Comparison
PODD vs EQR Comparison
Compare PODD & EQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PODD
- EQR
- Stock Information
- Founded
- PODD 2000
- EQR 1993
- Country
- PODD United States
- EQR United States
- Employees
- PODD N/A
- EQR N/A
- Industry
- PODD Medical/Dental Instruments
- EQR Real Estate Investment Trusts
- Sector
- PODD Health Care
- EQR Real Estate
- Exchange
- PODD Nasdaq
- EQR Nasdaq
- Market Cap
- PODD 22.1B
- EQR 24.5B
- IPO Year
- PODD 2007
- EQR 1993
- Fundamental
- Price
- PODD $333.84
- EQR $59.37
- Analyst Decision
- PODD Strong Buy
- EQR Buy
- Analyst Count
- PODD 18
- EQR 11
- Target Price
- PODD $354.17
- EQR $70.82
- AVG Volume (30 Days)
- PODD 562.0K
- EQR 2.7M
- Earning Date
- PODD 11-06-2025
- EQR 10-28-2025
- Dividend Yield
- PODD N/A
- EQR 4.68%
- EPS Growth
- PODD N/A
- EQR 24.49
- EPS
- PODD 3.45
- EQR 3.03
- Revenue
- PODD $2,521,800,000.00
- EQR $3,078,827,000.00
- Revenue This Year
- PODD $29.32
- EQR $5.00
- Revenue Next Year
- PODD $18.37
- EQR $3.68
- P/E Ratio
- PODD $96.64
- EQR $19.51
- Revenue Growth
- PODD 27.11
- EQR 4.69
- 52 Week Low
- PODD $230.05
- EQR $58.38
- 52 Week High
- PODD $353.50
- EQR $78.32
- Technical
- Relative Strength Index (RSI)
- PODD 58.72
- EQR 41.52
- Support Level
- PODD $311.51
- EQR $59.06
- Resistance Level
- PODD $341.03
- EQR $60.02
- Average True Range (ATR)
- PODD 12.17
- EQR 1.07
- MACD
- PODD 1.52
- EQR 0.05
- Stochastic Oscillator
- PODD 86.32
- EQR 42.67
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.
About EQR Equity Residential of Beneficial Interest
Equity Residential owns a portfolio of 312 apartment communities with over 84,000 units and is developing two additional properties with 655 units. The company focuses on owning large, high-quality properties in the urban and suburban submarkets of Southern California, San Francisco, Washington, D.C., New York, Seattle, and Boston.